Cargando…

A Comment on Ion Channels as Pharmacological Targets in Oncology

Detalles Bibliográficos
Autores principales:	Becchetti, Andrea, Arcangeli, Annarosa
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2008
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483335/ https://www.ncbi.nlm.nih.gov/pubmed/18663136 http://dx.doi.org/10.1085/jgp.200810069

Ejemplares similares

New Trends in Cancer Therapy: Targeting Ion Channels and Transporters
por: Arcangeli, Annarosa, et al.
Publicado: (2010)

The role of ion channels and transporters in cell proliferation and cancer
por: Becchetti, Andrea, et al.
Publicado: (2013)

High throughput clone screening on overexpressed hERG1 and Kv1.3 potassium channels using ion channel reader (ICR) label free technology
por: Montalbano, Alberto, et al.
Publicado: (2023)

Ion Channel Targeting with Antibodies and Antibody Fragments for Cancer Diagnosis
por: Duranti, Claudia, et al.
Publicado: (2019)

Deregulation of Ion Channel and Transporter Encoding Genes in Pediatric Gliomas
por: Masselli, Marika, et al.
Publicado: (2012)

Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels
por: Pillozzi, S, et al.
Publicado: (2016)

K(V)11.1 Potassium Channel and the Na(+)/H(+) Antiporter NHE1 Modulate Adhesion-Dependent Intracellular pH in Colorectal Cancer Cells
por: Iorio, Jessica, et al.
Publicado: (2020)

Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K
por: Petroni, Giulia, et al.
Publicado: (2020)

Correction: Clarithromycin inhibits autophagy in colorectal cancer by regulating the hERG1 potassium channel interaction with PI3K
por: Petroni, Giulia, et al.
Publicado: (2020)

Data describing the effects of potassium channels modulators on outward currents measured in human lymphoma cell lines
por: Montalbano, Alberto, et al.
Publicado: (2020)

Ion Channels in Hematopoietic and Mesenchymal Stem Cells
por: Pillozzi, Serena, et al.
Publicado: (2012)

In Response to Comment On: Why Racial Justice Matters in Radiation Oncology
por: Gibbs, Iris C., et al.
Publicado: (2020)

Comment on “scrutinizing predatory journals in pharmacology and calculating their predatory rate”
por: Kakamad, Fahmi Hussein, et al.
Publicado: (2019)

Data describing the effects of the Macrolide Antibiotic Clarithromycin on preclinical mouse models of Colorectal Cancer
por: Petroni, Giulia, et al.
Publicado: (2019)

Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy
por: Hofschröer, Verena, et al.
Publicado: (2021)

The Interaction between hERG1 and β1 Integrins Modulates hERG1 Current in Different Pathological Cell Models
por: Chioccioli Altadonna, Ginevra, et al.
Publicado: (2022)

The Activity of K(V)11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Adenocarcinoma Cells
por: Manoli, Sagar, et al.
Publicado: (2019)

Comment on: ‘Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?’
por: Bielack, S S
Publicado: (2012)

Can selectivity be functionally modulated in ion channels?
por: Fesce, Riccardo, et al.
Publicado: (2011)

Comment on “The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region” and reflections from the Italian Association of Oncology Nurses
por: Biagioli, Valentina, et al.
Publicado: (2020)

Comments on: “In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea”
por: Gil, Daniel
Publicado: (2018)

Reply: Comment on ‘Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?’
por: Davies, J E, et al.
Publicado: (2012)

Comment on “Replacing the NCCN’s Blocks with Wheels: How Should Consideration of Societal Spending be Incorporated into Oncology Practice?”
por: Koh, Wui-Jin, et al.
Publicado: (2020)

Test of Poisson-Nernst-Planck Theory in Ion Channels
Publicado: (1999)

Ion channel pharmacology /
Publicado: (1998)

The role of protease-activated receptors in regulating other ion channels
por: Eisenhut, Michael
Publicado: (2014)

The Potential of PET/MRI Imaging in Oncology: a Comment to a Summary Report of the First PET/MRI Workshop in Tuebingen in 2012
por: Czernin, Johannes, et al.
Publicado: (2013)

Comment on “Oncological Outcomes After Anastomotic Leakage After Surgery for Colon or Rectal Cancer: Increased Risk of Local Recurrence”
por: Pai, Esha, et al.
Publicado: (2022)

Using hierarchical thermodynamic linkage analysis to study ion channel gating
por: Shem-Ad, Tzilhav, et al.
Publicado: (2013)

A minimalist model for ion partitioning and competition in a K(+) channel selectivity filter
por: Kast, Stefan M., et al.
Publicado: (2011)

Comment on “Identification of Novel G Protein–Coupled Receptor 143 Ligands as Pharmacologic Tools for Investigating X-Linked Ocular Albinism”
por: McKay, Brian S., et al.
Publicado: (2017)

Target promiscuity and heterogeneous effects of tarantula venom peptides affecting Na(+) and K(+) ion channels.
por: Redaelli, Elisa, et al.
Publicado: (2010)

Dysfunctional Hyperpolarization-Activated Cyclic Nucleotide-gated Ion Channels in Cardiac Diseases
por: Zhao, Xiaoqi, et al.
Publicado: (2016)

Homelessness and COVID-19: Leaving No One Behind
por: Ralli, Massimo, et al.
Publicado: (2021)

Comment on “Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort”
por: Meng, Yufan, et al.
Publicado: (2023)

Comment on “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review”
por: Delicata, Nicholas-Paul, et al.
Publicado: (2016)

Editor's comment
por: Bhattacharya, S.
Publicado: (2011)

Comment on editorial
por: Sarkar, H. S.
Publicado: (2013)

An Author's Comment
por: Frankenburg, Charis U.
Publicado: (1962)

Author Response: Comment on “Identification of Novel G Protein–Coupled Receptor 143 Ligands as Pharmacologic Tools for Investigating X-Linked Ocular Albinism”
por: De Filippo, Elisabetta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kufb7dhnqg0teeqgsc8b6iq5ad